Rocket Lab's Costly Delay: Why Orbit Remains a Risky Bet for Investors
There is an old, slightly weary joke in the City: if you want to become a millionaire in the commercial space game, start as a billionaire and wait five minutes. Rocket Lab gave the market another sharp reminder of that bitter reality this week. The firm announced its shiny next-generation Neutron rocket will not grace the skies before 2027, pushing back its maiden flight.
Naturally, Wall Street reacted with all the delicate nuance of a dropped spanner. Shares tumbled sharply in after-hours trading.
I am hardly shocked. Rocketry is notoriously unforgiving of tidy spreadsheet timetables. Yet, for investors who bought the seductive narrative of Rocket Lab snapping at Elon Musk's heels, this delay stings. Electron, the company's current workhorse, is an admirable machine. It launches with genuine reliability and brings in honest revenue. But nobody priced this stock simply to watch miniature payloads potter into low orbit.
Investors paid for tomorrow. They paid for Neutron, a medium-lift brute designed to muscle directly into the lucrative commercial constellation market.
A rocket on a computer screen cannot carry cargo.
Every month Neutron sits on a drawing board, SpaceX digs its commercial moat a little deeper. When looking at this sector, particularly through lenses like the SpaceX IPO Ripple Effect | What's Next to Watch, one realises how brutal the arithmetic becomes. Customers with multi-million-pound satellites cannot simply twiddle their thumbs in cleanrooms until 2027. They will knock on the door of whoever can take them upstairs today.
Could Rocket Lab weather the delay? Quite possibly. The steady cash from Electron provides a welcome cushion, which may spare shareholders from dilutive, cap-in-hand equity raises in the immediate term. But launch windows wait for no one, and competitive advantages in aerospace are brittle things.
To me, this is a classic demonstration of orbital economics. The commercial space sector could well create vast value over the next decade, but the journey will never be a straight vertical line. Share prices can slide just as fast as they climb, and technical promises are not ironclad guarantees. If you are tempted to back the sector, pack a parachute. Rocket science remains, quite stubbornly, rocket science.
